Literature DB >> 17704093

Atrial enhancement by cardiovascular magnetic resonance in cardiac amyloidosis.

Jonathan C Lyne1, Joanna Petryka, Dudley J Pennell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704093     DOI: 10.1093/eurheartj/ehm351

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

2.  Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function.

Authors:  Raymond Y Kwong; Bobak Heydari; Siddique Abbasi; Kevin Steel; Mouaz Al-Mallah; Henry Wu; Rodney H Falk
Journal:  Am J Cardiol       Date:  2015-05-22       Impact factor: 2.778

3.  Delayed gadolinium enhancement in the atrial wall: a novel finding in 3 patients with rheumatic heart disease.

Authors:  Jabi Shriki; Brenna Talkin; Isac C Thomas; Ali Farvid; Patrick M Colletti
Journal:  Tex Heart Inst J       Date:  2011

4.  [MRI in cardiac sarcoidosis and amyloidosis].

Authors:  K U Bauner; B Wintersperger
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

Review 5.  Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment-A Systematic Review.

Authors:  Aidonis Rammos; Vasileios Meladinis; Georgios Vovas; Dimitrios Patsouras
Journal:  Radiol Res Pract       Date:  2017-11-15

6.  Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.

Authors:  Maarten P van den Berg; Bart A Mulder; Sebastiaan H C Klaassen; Alexander H Maass; Dirk J van Veldhuisen; Peter van der Meer; Hans L A Nienhuis; Bouke P C Hazenberg; Michiel Rienstra
Journal:  Eur Heart J       Date:  2019-04-21       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.